![Kelly Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Gold
Director of Finance/CFO at
CAMP4 THERAPEUTICS CORPORATION
Net worth: 297 980 $ as of 2026-05-30
Profile
Kelly Gold is currently Director & Director-Individual Fundraising at Education First, Independent Director at X4 Pharmaceuticals, Inc. starting in 2026, and Chief Financial Officer at CAMP4 Therapeutics Corp.
since 2022.
Former roles include Associate Director-Strategic Corporate Finance at Biogen, Inc. from 2014 to 2017 and Partner at Deutsche Bank AG (New York Branch) from 2009 to 2013.
Education includes an undergraduate degree from Queen's University and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-31 | 67,877 ( 0.14% ) | 297 980 $ | 2026-05-30 |
Kelly Gold active positions
| Companies | Position | Start |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Director of Finance/CFO | 2022-03-31 |
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 2026-05-31 |
Education First
 Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Director/Board Member | - |
Former positions of Kelly Gold
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2016-12-31 |
Deutsche Bank AG (New York Branch)
 Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Corporate Officer/Principal | 2012-12-31 |
Training of Kelly Gold
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Deutsche Bank AG (New York Branch)
Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Education First
Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Miscellaneous |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
- Stock Market
- Insiders
- Kelly Gold
Choose MarketScreener 
